DK175504B1 - Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf - Google Patents

Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf Download PDF

Info

Publication number
DK175504B1
DK175504B1 DK198700621A DK62187A DK175504B1 DK 175504 B1 DK175504 B1 DK 175504B1 DK 198700621 A DK198700621 A DK 198700621A DK 62187 A DK62187 A DK 62187A DK 175504 B1 DK175504 B1 DK 175504B1
Authority
DK
Denmark
Prior art keywords
oil
pregnanolone
amount
water
final preparation
Prior art date
Application number
DK198700621A
Other languages
Danish (da)
English (en)
Other versions
DK62187A (da
DK62187D0 (da
Inventor
Roland Ingolf Jeppsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of DK62187D0 publication Critical patent/DK62187D0/da
Publication of DK62187A publication Critical patent/DK62187A/da
Application granted granted Critical
Publication of DK175504B1 publication Critical patent/DK175504B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK198700621A 1986-02-13 1987-02-06 Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf DK175504B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8600632 1986-02-13
SE8600632A SE8600632D0 (sv) 1986-02-13 1986-02-13 Novel pharmaceutical composition

Publications (3)

Publication Number Publication Date
DK62187D0 DK62187D0 (da) 1987-02-06
DK62187A DK62187A (da) 1987-08-14
DK175504B1 true DK175504B1 (da) 2004-11-15

Family

ID=20363448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198700621A DK175504B1 (da) 1986-02-13 1987-02-06 Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf

Country Status (14)

Country Link
US (1) US5028600A (fi)
EP (1) EP0233849B1 (fi)
JP (1) JPH0788305B2 (fi)
AT (1) ATE64526T1 (fi)
CA (1) CA1301651C (fi)
DE (1) DE3770830D1 (fi)
DK (1) DK175504B1 (fi)
ES (1) ES2037742T3 (fi)
FI (1) FI88676C (fi)
GR (1) GR3002299T3 (fi)
HK (1) HK83293A (fi)
NO (1) NO175040B (fi)
SE (1) SE8600632D0 (fi)
SG (1) SG102892G (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302295D0 (sv) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab New pharmaceutical composition
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
AU8779898A (en) * 1997-08-11 1999-03-01 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
US20020155161A1 (en) * 2000-12-29 2002-10-24 Deckelbaum Richard J. Use of IV emulsions with different triglyceride composition, particle size and apolipoprotein E for targeted tissue delivery of hydrophobic compounds
NZ537945A (en) * 2002-07-02 2007-08-31 Altana Pharma Ag Ciclesonide-containing sterile aqueous suspension
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP2008512447A (ja) * 2004-09-13 2008-04-24 ブハラット セルムズ アンド ヴァクシンズ リミテッド 防腐作用を有する静脈投与用の安定な乳剤組成物
EP2663326B2 (en) * 2011-01-14 2021-09-29 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US10478505B2 (en) 2011-09-23 2019-11-19 The Regents Of The University Of California Edible oils to enhance delivery of orally administered steroids
LT2806877T (lt) 2012-01-23 2019-12-10 Sage Therapeutics Inc Neuroaktyvios steroidų kompozicijos, apimančios alopregnanolono ir sulfobutilo eterio beta-ciklodekstrino kompleksą
WO2014028398A2 (en) 2012-08-13 2014-02-20 The Regents Of The University Of California Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
EP2925327B1 (en) 2012-11-30 2024-01-10 The Regents of The University of California Allopregnanolone for treating, reducing or mitigating symptoms of post-partum depression
WO2017156103A1 (en) 2016-03-08 2017-09-14 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JP2022514991A (ja) * 2018-12-10 2022-02-16 ハロー・サイエンス・エル・エル・シー 安定な麻酔薬製剤および関連する剤形
CA3151334C (en) * 2019-08-19 2024-04-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Topical neurosteroid formulations
CN114344309B (zh) * 2021-12-30 2024-02-06 南京迈诺威医药科技有限公司 一种别孕烷醇酮衍生物自乳化制剂及其制备方法
US11969434B1 (en) 2022-08-29 2024-04-30 Lipocine Inc. Oral allopregnanolone compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1215702B (de) * 1962-07-03 1966-05-05 Merck Ag E Verfahren zur Herstellung von 1alpha-Alkylthio-3-keto-androstanen
CA895860A (en) * 1969-11-05 1972-03-21 Kruger Gunther PROCESS FOR THE PREPARATION OF 3.alpha.-HYDROXY-5.beta.-PREGNAN-20-ONE
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS5716818A (en) * 1981-04-25 1982-01-28 Green Cross Corp:The Steroid fatty emulsion
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液

Also Published As

Publication number Publication date
GR3002299T3 (en) 1992-12-30
SE8600632D0 (sv) 1986-02-13
DK62187A (da) 1987-08-14
ATE64526T1 (de) 1991-07-15
DK62187D0 (da) 1987-02-06
JPH0788305B2 (ja) 1995-09-27
DE3770830D1 (de) 1991-07-25
EP0233849B1 (en) 1991-06-19
SG102892G (en) 1992-12-04
NO175040B (no) 1994-05-16
NO175040C (fi) 1994-08-24
HK83293A (en) 1993-08-20
FI870589A0 (fi) 1987-02-12
FI870589A (fi) 1987-08-14
US5028600A (en) 1991-07-02
FI88676B (fi) 1993-03-15
NO870560L (no) 1987-08-14
NO870560D0 (no) 1987-02-12
CA1301651C (en) 1992-05-26
EP0233849A1 (en) 1987-08-26
JPS62192322A (ja) 1987-08-22
FI88676C (fi) 1993-06-28
ES2037742T3 (es) 1993-07-01

Similar Documents

Publication Publication Date Title
DK175504B1 (da) Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf
KR100410937B1 (ko) 프로포폴을 함유하는 혈관주사용 마취제 조성물
CA1333993C (en) Drug carriers
US5651991A (en) Drug carriers
AT408945B (de) Orale pharmazeutische zubereitung
EP2252267A2 (de) Lyophilisierte nanoemulsion
CN101496787B (zh) 一种荷电性的前列腺素e1脂微球注射液及其制备方法
WO2016124162A1 (zh) 一种丙泮尼地药物组合物及其制备方法
JPH02203A (ja) 薬物担体
JPS62270521A (ja) フルルビプロフエン眼投与製剤
JPH09512794A (ja) マラリアの治療用のハロファントリン遊離塩基および組成物
US6069165A (en) Pharmaceutical compositions containing amisulpride and their therapeutic applications
JPH10510267A (ja) スフィンゴ脂質の投与に適したエマルジョン及びその使用
JP2019510048A (ja) 週1回又は隔週1回の投与に適したリラグルチドの粘弾性ゲル
EP4062904A1 (en) Liquid crystalline structure-forming omega-3-fatty acid composition
JP3074734B2 (ja) 分散製剤
JP2930242B2 (ja) 非経口投与用エマルジヨン
RU2141313C1 (ru) Фармацевтическая эмульсия, содержащая биологически активные стероиды, и способ получения эмульсии
EP0418004B1 (en) Preventive and therapeutic agent for hepatitis
EP0350864B1 (en) Aqueous solution containing fat-soluble vitamin k
JP2022514991A (ja) 安定な麻酔薬製剤および関連する剤形
CN108653204B (zh) 一种多烯磷脂酰胆碱注射液药物组合物及其制备方法
JPH0489430A (ja) 低血圧維持剤
DE3411910A1 (de) Galenische zubereitung
MXPA96004611A (es) Base libre de halogenofantrina para el tratamiento de malaria y composiciones

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK